Nasofan nasal spray 50 mcg/dose bottle 120 doses

Nasal spray "Nazofan" is used for the prevention and treatment of year-round and seasonal allergic rhinitis (including hay fever).

Composition

The active substance is fluticasone propionate (one dose contains 50 mcg of fluticasone propionate).

Excipients: anhydrous glucose, dispersed cellulose, phenylethyl alcohol, benzalkonium chloride solution, polysorbate 80, purified water.

Contraindication

Hypersensitivity to fluticasone propionate or other components of the drug.

Method of application

"Nasofan" is intended for intranasal use only.

Before first use, Nasofan must be primed by pressing and releasing the pump 6 times. If the nasal spray has not been used for 7 days, it must be primed by pressing and releasing the pump a sufficient number of times until a copious spray appears.

Adults and children over 12 years of age: 2 sprays in each nostril once a day, preferably in the morning. In some cases, the dose may be 2 sprays in each nostril twice a day. The maximum daily dose should not exceed 4 sprays in each nostril (400 mcg). The minimum dose sufficient for a therapeutic effect should be used.

Children aged 4 to 11 years: one spray in each nostril once daily, preferably in the morning. In some cases, the dose may be one spray in each nostril twice daily. The maximum daily dose should not exceed 2 sprays in each nostril (200 mcg). The lowest dose sufficient to effectively control symptoms should be used.

The duration of treatment is determined by the doctor depending on the patient's clinical condition and response to treatment.

Application features

Pregnant women

During pregnancy and lactation, fluticasone propionate should be used only if the expected benefit to the mother outweighs the potential risk to the fetus/child. There is insufficient evidence of safety during human pregnancy. Direct intranasal administration provides minimal systemic exposure.

The excretion of fluticasone propionate into breast milk has not been studied. It is unlikely that the drug can be detected in breast milk after intranasal administration.

Children

The drug is not recommended for children under 4 years of age, as there is insufficient experience with the drug in this age group.

Drivers

The effect of this drug on the reaction speed when driving vehicles or other mechanisms is insignificant or absent.

Overdose

No cases of acute or chronic overdose of the drug "Nazofan" have been reported.

The use of doses exceeding the recommended ones for a long time may lead to temporary suppression of adrenal function. In such patients, treatment with fluticasone propionate should be continued at doses sufficient to control symptoms; adrenal function will recover after a few days, which can be checked by determining the level of cortisol in the blood plasma.

Side effects

On the part of the immune system: anaphylactoid / anaphylactic reactions, bronchospasm, hypersensitivity reactions, skin rash, angioedema (mainly of the face and tongue).

From the nervous system: headache, unpleasant taste, unpleasant smell.

On the part of the organs of vision: cataracts, glaucoma (observed with prolonged use), increased intraocular pressure, impaired visual acuity.

Skin and subcutaneous tissue disorders: skin ulcers.

Respiratory system: nosebleeds, dryness and irritation in the nose and throat, perforation of the nasal septum, ulcers of the mucous membrane (usually in patients who have previously undergone surgery on the nasal cavity).

Storage conditions

Store at a temperature not exceeding 25 °C, out of the reach of children.

Shelf life - 3 years (after opening - 3 months).